The safety and efficacy of zidovudine (AZT) in the treatment of subjects with mildly symptomatic human immunodeficiency virus type 1 (HIV) infection: a double-blind …. Fischl MA. MA Fischl, DD Richman, N Hansen… - Annals of internal …, 1990 - acpjournals.org GSID: nf8TkYY-lukJ
The duration of zidovudine benefit in persons with asymptomatic HIV infection: prolonged evaluation of protocol 019 of the AIDS Clinical Trials Group. [No authors listed] PA Volberding, SW Lagakos, JM Grimes, DS Stein… - Jama, 1994 - jamanetwork.com GSID: 1PdZcVwr0KEJ
Effects of zidovudine therapy in minority and other subpopulations with early HIV infection. Fischl MA. S Lagakos, MA Fischl, DS Stein, L Lim, P Volberding - JAMA, 1991 - jamanetwork.com GSID: JlMtZqyywIcJ
Racial differences in the use of drug therapy for HIV disease in an urban community. Gopalan R. RD Moore, D Stanton, R Gopalan… - New England Journal …, 1994 - Mass Medical Soc GSID: 77AvWWOh2OgJ
Racial differences in factors that influence the willingness to participate in medical research studies. Lynch CF. VL Shavers, CF Lynch, LF Burmeister - Annals of epidemiology, 2002 - Elsevier GSID: Od84pddNJQIJ
Zidovudine: five years later. [No authors listed] GX McLeod, SM Hammer - Annals of Internal Medicine, 1992 - acpjournals.org GSID: nbx4y03UmX8J
